TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06435091 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT06490757 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT04852965 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04852965 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT06706687 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study NCT06701903 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04040660 — Predictive Biomarker (PRD): DPT mRNA
Genes: DPT
Study NCT05377788 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05135000 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05135000 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05732090 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04579367 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04579367 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06333574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04920162 — Predictive Biomarker (PRD): ITGBL1 mRNA
Genes: ITGBL1; OSCP; TIED
Study NCT05138016 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05138016 — Safety Biomarker (SAF): BDNF
Study NCT05535946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06156631 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05148234 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05854745 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT06600347 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05673083 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT06095362 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04846075 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04846075 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04846075 — Safety Biomarker (SAF): BDNF
Study NCT06281756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04457323 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05839652 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06429215 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05886790 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05886790 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06120400 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05620628 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06612099 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05165342 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05165342 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06001658 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05839275 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05743465 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06159790 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06159790 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06419465 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06317051 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06317051 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04544475 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05774236 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT04756505 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04756505 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05653622 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06619353 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06621303 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04763577 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04763577 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06066827 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06494696 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06418074 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06236126 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04730258 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study NCT05094206 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05094206 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06124625 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04832958 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05351437 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05502042 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT05783622 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05920707 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06054191 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05725070 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06169371 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06169371 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05902988 — Predictive Biomarker (PRD): KIF18A mRNA
Genes: KIF18A; OK/SW-cl.108
Study NCT06194864 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05140655 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05140655 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05182463 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05863078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06544265 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04765345 — Predictive Biomarker (PRD): PCDH15 mRNA
Genes: PCDH15; USH1F
Study NCT05249556 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT06490913 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06136377 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06080191 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06567977 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT06072326 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study NCT04981470 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05142475 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05607368 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT06098612 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05623579 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04931784 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06567132 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT06567132 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06567132 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT06567132 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06157515 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05388500 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05970341 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04798027 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04798027 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05344794 — Predictive Biomarker (PRD): PNOC mRNA
Genes: PNOC; OFQ
Study NCT05134740 — Predictive Biomarker (PRD): MAGEA4 mRNA
Genes: MAGEA4; MAGE4
Study NCT05134740 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT06433609 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05079022 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05079022 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06653881 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05280418 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT05782400 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05007951 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05970900 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04873479 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT05922865 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06347705 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05514912 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT05369104 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT04833764 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT05113875 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05513937 — Predictive Biomarker (PRD): NEB mRNA
Genes: NEB
Study NCT05513937 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06343948 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06343948 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05265078 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05668143 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05891379 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT05770102 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05394831 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05990608 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04907799 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT05520255 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05336864 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06276556 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06587958 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05156970 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05049096 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04977388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000761 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000761 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06190756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06592560 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05548348 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05548348 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05426889 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT05290155 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06603142 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06586801 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05002270 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05313451 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT06003114 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06003114 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06003114 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06587880 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06588049 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04673292 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04637282 — Predictive Biomarker (PRD): CLN3 mRNA
Genes: CLN3; BTS
Study NCT06600529 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study NCT06602037 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT06602037 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05536310 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05297409 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04650815 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05587855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05120895 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05120895 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06686602 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06686602 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06602869 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT06602869 — Predictive Biomarker (PRD): MNT mRNA
Genes: MNT; BHLHD3; ROX
Study NCT06602869 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06595069 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06588959 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05821738 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05827939 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06703580 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04624711 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06703723 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05085639 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06706570 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04941040 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05576389 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06253585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04035070 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05573555 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05665166 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study NCT06305702 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05449535 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05449535 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05565105 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04738812 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04501770 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04935099 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04935099 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05769153 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06547086 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04953494 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04943913 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04774289 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05432882 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05432882 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06271941 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04561206 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06579898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05002127 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05412056 — Safety Biomarker (SAF): Interleukin 1
Study NCT06630585 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05618613 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04294290 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06313476 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05388032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05228795 — Predictive Biomarker (PRD): GPC1 mRNA
Genes: GPC1
Study NCT04888429 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06488417 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04782544 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05947487 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05807360 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05798442 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05047731 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06496282 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06496282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06496282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05740683 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT06648369 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06648512 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06648057 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06361732 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT06361732 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT06361732 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04919109 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03546309 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT05619809 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05650814 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05837130 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT05440162 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06442943 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02094222 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT05601193 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT05632809 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT05440942 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT05203497 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05203497 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06396091 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05773729 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05542420 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05620706 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT05686161 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05806567 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT05051605 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05051605 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study NCT05731986 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04755101 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05768945 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06443866 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05601375 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05076006 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05076006 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study NCT05652686 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study NCT05533528 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05937178 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06272318 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04686175 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT05913570 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06002529 — Safety Biomarker (SAF): Complement factor D
Genes: CFD; DF; PFD
Study NCT06002529 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06002529 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06002529 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06002529 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT06002529 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05108740 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05108740 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05073328 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06620068 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06620068 — Predictive Biomarker (PRD): VEGFB mRNA
Genes: VEGFB; VRF
Study NCT06620068 — Predictive Biomarker (PRD): VEGFC mRNA
Genes: VEGFC
Study NCT06620068 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT06620068 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor